Adamis Pharmaceuticals reported $-808070 in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adamis Pharmaceuticals ADMP:US USD -808070 3.81M
Adma Biologics ADMA:US USD 100.38M 14.02M
Brainstorm Cell Therapeutics BCLI:US USD 1.39M 6.46M
Cara Therapeutics CARA:US USD 158.78M 26.04M
GlaxoSmithKline GSK:LN GBP 10.6B 1.45B
Glaxosmithkline GSK:US GBP 10.6B 1.45B